| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.90e-08 | 44 | 152 | 7 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.14e-06 | 71 | 152 | 7 | GO:0042054 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TCF7L2 SPIB FOSB TBX21 SREBF1 MECOM MEIS3 IRX6 FOXA1 JUNB KMT2D DMRT2 EGR1 ZNF341 GLI1 PRDM16 SMAD2 | 1.54e-06 | 566 | 152 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TCF7L2 SPIB FOSB TBX21 SREBF1 MECOM MEIS3 IRX6 FOXA1 JUNB KMT2D DMRT2 EGR1 GLI1 PRDM16 SMAD2 | 6.01e-06 | 560 | 152 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.31e-05 | 68 | 152 | 6 | GO:0016279 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.39e-05 | 103 | 152 | 7 | GO:0008276 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.42e-05 | 20 | 152 | 4 | GO:0042800 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.42e-05 | 69 | 152 | 6 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 2.35e-05 | 8 | 152 | 3 | GO:0140948 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 2.35e-05 | 8 | 152 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 4.99e-05 | 10 | 152 | 3 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 4.99e-05 | 10 | 152 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | transcription factor binding | SETD1A TCF7L2 NAB2 SREBF1 DAZAP2 BCOR FOXA1 ZFPM2 DACT1 JUNB AHR NR5A1 TAF1 PRDM16 HSPA4 RBFOX2 SMAD2 | 6.22e-05 | 753 | 152 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | histone modifying activity | 6.65e-05 | 229 | 152 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXS1 TCF7L2 SPIB FOSB TBX21 SREBF1 MECOM MEIS3 IRX6 FOXA1 ZNF768 HOXA3 JUNB DMRT2 EGR1 ZNF341 GLI1 AHR NR5A1 PAX7 PRDM16 TCF7L1 SMAD2 | 6.77e-05 | 1244 | 152 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 9.05e-05 | 12 | 152 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXS1 TCF7L2 SPIB FOSB TBX21 SREBF1 MECOM MEIS3 IRX6 FOXA1 ZNF768 HOXA3 JUNB DMRT2 EGR1 ZNF341 GLI1 AHR NR5A1 PAX7 PRDM16 TCF7L1 SMAD2 | 9.36e-05 | 1271 | 152 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXS1 TCF7L2 SPIB FOSB TBX21 SREBF1 MECOM MEIS3 IRX6 BCOR FOXA1 ZNF768 HOXA3 JUNB DMRT2 EGR1 ZNF341 GLI1 AHR NR5A1 TAF1 PAX7 PRDM16 TCF7L1 SMAD2 | 1.07e-04 | 1459 | 152 | 25 | GO:0000977 |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.17e-04 | 13 | 152 | 3 | GO:0046974 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.53e-04 | 105 | 152 | 6 | GO:0008170 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXS1 TCF7L2 SPIB FOSB TBX21 SREBF1 MECOM MEIS3 IRX6 FOXA1 ZNF768 HOXA3 JUNB KMT2D DMRT2 EGR1 ZNF341 GLI1 AHR NR5A1 PAX7 PRDM16 TCF7L1 SMAD2 | 1.69e-04 | 1412 | 152 | 24 | GO:0000981 |
| GeneOntologyMolecularFunction | methyltransferase activity | 2.32e-04 | 213 | 152 | 8 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.25e-04 | 224 | 152 | 8 | GO:0016741 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 3.53e-04 | 172 | 152 | 7 | GO:0008757 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SETD1A TCF7L2 DAZAP2 BCOR FOXA1 ZFPM2 DACT1 AHR TAF1 PRDM16 HSPA4 RBFOX2 SMAD2 | 5.21e-04 | 582 | 152 | 13 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.35e-04 | 303 | 152 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | POZ domain binding | 5.67e-04 | 5 | 152 | 2 | GO:0031208 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | RBPMS NAB2 TSG101 BCOR KMT2E ZFPM2 TAF6L KMT2C KMT2D ZMIZ2 PRDM16 RBFOX2 | 1.26e-03 | 562 | 152 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | RBPMS A1CF STON1 MAP1A NAB2 TSG101 SORBS1 BCOR KMT2E ZFPM2 YTHDF1 TAF6L KMT2C KMT2D ZMIZ2 TNRC6A PRDM16 GAB1 RBFOX2 | 1.32e-03 | 1160 | 152 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | RBPMS A1CF STON1 MAP1A NAB2 TSG101 SORBS1 BCOR KMT2E ZFPM2 YTHDF1 TAF6L KMT2C DLGAP3 KMT2D ZMIZ2 TNRC6A PRDM16 GAB1 RBFOX2 | 3.36e-03 | 1356 | 152 | 20 | GO:0060090 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TCF7L2 SPIB FOSB TBX21 ASH1L SREBF1 AKNA MECOM MEIS3 IRX6 FOXA1 ZFPM2 RPRD1B KMT2C JUNB KMT2D DMRT2 ATXN1 EGR1 GLI1 ZMIZ2 AHR LRP6 NR5A1 TAF1 PAX7 PRDM16 TCF7L1 SMAD2 | 2.26e-07 | 1390 | 150 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | gland development | TCF7L2 CEACAM5 MAN2A1 PSEN2 ASH1L PLXND1 FOXA1 HOXA3 ESRP2 LSR GLI1 AHR LRP6 NR5A1 PLXNA1 SMAD2 CCDC40 | 6.78e-07 | 558 | 150 | 17 | GO:0048732 |
| GeneOntologyBiologicalProcess | respiratory system development | MAN2A1 PSEN2 SREBF1 FOXA1 ATXN1L ZFPM2 ESRP2 ATXN1 GLI1 LRP6 SMAD2 CCDC40 | 2.47e-06 | 305 | 150 | 12 | GO:0060541 |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.45e-06 | 15 | 150 | 4 | GO:0043328 | |
| GeneOntologyBiologicalProcess | lung development | MAN2A1 PSEN2 SREBF1 FOXA1 ATXN1L ZFPM2 ESRP2 ATXN1 GLI1 SMAD2 CCDC40 | 4.55e-06 | 269 | 150 | 11 | GO:0030324 |
| GeneOntologyBiologicalProcess | respiratory tube development | MAN2A1 PSEN2 SREBF1 FOXA1 ATXN1L ZFPM2 ESRP2 ATXN1 GLI1 SMAD2 CCDC40 | 5.24e-06 | 273 | 150 | 11 | GO:0030323 |
| GeneOntologyBiologicalProcess | stress granule assembly | 5.98e-06 | 36 | 150 | 5 | GO:0034063 | |
| GeneOntologyBiologicalProcess | epithelium development | ROBO4 TCF7L2 CEACAM5 PSEN2 TRIOBP PUM2 MECOM TSG101 PLXND1 EXTL3 FOXA1 LGR5 ESRP2 ENAM DACT1 LSR DMRT2 GLI1 AHR LRP6 NR5A1 PAX7 KDF1 ADAMTSL4 PLXNA1 SMAD2 CCDC40 | 6.94e-06 | 1469 | 150 | 27 | GO:0060429 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TCF7L2 CEACAM5 MAN2A1 PSEN2 NAB2 ASH1L TRIOBP MECOM MEIS3 IRX6 PLXND1 BCOR FOXA1 ZFPM2 HOXA3 ESRP2 ENAM GLI1 AHR LRP6 PAX7 PLXNA1 SMAD2 CCDC40 | 1.52e-05 | 1269 | 150 | 24 | GO:0009887 |
| GeneOntologyBiologicalProcess | tube development | ROBO4 TCF7L2 CEACAM5 MAN2A1 PSEN2 SREBF1 MECOM PLXND1 FOXA1 LGR5 ATXN1L ZFPM2 ESRP2 DACT1 JUNB PIK3C2A ATXN1 AMOT GLI1 AHR LRP6 PAX7 GAB1 SMAD2 CCDC40 | 2.66e-05 | 1402 | 150 | 25 | GO:0035295 |
| GeneOntologyBiologicalProcess | pattern specification process | PSEN2 MEIS3 BCOR FOXA1 HOXA3 DMRT2 GLI1 ARC LRP6 PAX7 DNAH5 TCF7L1 SMAD2 CCDC40 | 3.11e-05 | 526 | 150 | 14 | GO:0007389 |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 4.14e-05 | 27 | 150 | 4 | GO:0032511 | |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 5.25e-05 | 2 | 150 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | memory | 5.93e-05 | 183 | 150 | 8 | GO:0007613 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXS1 TCF7L2 PSEN2 FOSB TBX21 NAB2 SREBF1 MECOM TSG101 IRX6 BCOR FOXA1 ATXN1L TENM2 ZFPM2 DACT1 ATXN1 EGR1 AHR TAF1 PRDM16 TCF7L1 RBFOX2 SMAD2 | 7.25e-05 | 1399 | 150 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXS1 TCF7L2 PSEN2 FOSB TBX21 NAB2 SREBF1 MECOM TSG101 IRX6 BCOR FOXA1 ATXN1L TENM2 ZFPM2 DACT1 ATXN1 EGR1 AHR TAF1 PRDM16 TCF7L1 RBFOX2 SMAD2 | 8.47e-05 | 1413 | 150 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | embryo development | TCF7L2 MAN2A1 PSEN2 TRIOBP MECOM MEIS3 EYA2 BCOR FOXA1 ZFPM2 HOXA3 DACT1 JUNB KMT2D DMRT2 AMOT GLI1 LRP6 PAX7 KDF1 TCF7L1 GAB1 SMAD2 CCDC40 | 1.10e-04 | 1437 | 150 | 24 | GO:0009790 |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 1.32e-04 | 107 | 150 | 6 | GO:0009953 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.47e-04 | 37 | 150 | 4 | GO:0043162 | |
| GeneOntologyBiologicalProcess | negative regulation of female gonad development | 1.57e-04 | 3 | 150 | 2 | GO:2000195 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.57e-04 | 3 | 150 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | beta-catenin-TCF complex assembly | 1.57e-04 | 3 | 150 | 2 | GO:1904837 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport | 1.81e-04 | 39 | 150 | 4 | GO:0045324 | |
| GeneOntologyBiologicalProcess | regionalization | PSEN2 FOXA1 HOXA3 DMRT2 GLI1 ARC LRP6 PAX7 DNAH5 TCF7L1 SMAD2 CCDC40 | 2.01e-04 | 478 | 150 | 12 | GO:0003002 |
| GeneOntologyBiologicalProcess | lung alveolus development | 2.18e-04 | 75 | 150 | 5 | GO:0048286 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 2.36e-04 | 119 | 150 | 6 | GO:0072091 | |
| GeneOntologyBiologicalProcess | growth | FOXS1 PLXNA3 TCF7L2 CEACAM5 EIF4H PUM2 TSG101 EXTL3 BCAR1 ZFPM2 KMT2C KMT2D GLI1 AHR LRP6 PAX7 KDF1 ULK2 DCBLD2 PLXNA1 SMAD2 | 2.43e-04 | 1235 | 150 | 21 | GO:0040007 |
| GeneOntologyBiologicalProcess | endosome transport via multivesicular body sorting pathway | 2.66e-04 | 43 | 150 | 4 | GO:0032509 | |
| GeneOntologyBiologicalProcess | neural tube patterning | 3.18e-04 | 45 | 150 | 4 | GO:0021532 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | TCF7L2 MAN2A1 PSEN2 MECOM BCOR FOXA1 ZFPM2 HOXA3 DACT1 JUNB KMT2D DMRT2 AMOT LRP6 PAX7 GAB1 SMAD2 | 3.26e-04 | 906 | 150 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 3.31e-04 | 178 | 150 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 3.91e-04 | 85 | 150 | 5 | GO:0032092 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 3.96e-04 | 131 | 150 | 6 | GO:0010469 | |
| GeneOntologyBiologicalProcess | skin development | 4.12e-04 | 373 | 150 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | central nervous system development | IL34 PLXNA3 SETD1A DMXL2 TCF7L2 PSEN2 ROR1 AKNA MECOM MEIS3 ATXN1L LSR ATXN1 GLI1 LRP6 TAF1 PAX7 DNAH5 PLXNA1 RBFOX2 | 4.32e-04 | 1197 | 150 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TCF7L2 MAN2A1 PSEN2 MECOM BCOR FOXA1 ZFPM2 HOXA3 DACT1 JUNB KMT2D DMRT2 AMOT LRP6 PAX7 GAB1 SMAD2 | 4.34e-04 | 929 | 150 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | diencephalon development | 5.09e-04 | 90 | 150 | 5 | GO:0021536 | |
| GeneOntologyBiologicalProcess | multivesicular body sorting pathway | 5.15e-04 | 51 | 150 | 4 | GO:0071985 | |
| GeneOntologyBiologicalProcess | negative regulation of gonad development | 5.18e-04 | 5 | 150 | 2 | GO:1905940 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of terminal units involved in salivary gland branching | 5.18e-04 | 5 | 150 | 2 | GO:0060666 | |
| GeneOntologyBiologicalProcess | embryonic hindgut morphogenesis | 5.18e-04 | 5 | 150 | 2 | GO:0048619 | |
| GeneOntologyBiologicalProcess | brain development | PLXNA3 SETD1A DMXL2 TCF7L2 PSEN2 AKNA MECOM MEIS3 ATXN1L ATXN1 GLI1 LRP6 TAF1 DNAH5 PLXNA1 RBFOX2 | 5.32e-04 | 859 | 150 | 16 | GO:0007420 |
| GeneOntologyBiologicalProcess | tube morphogenesis | ROBO4 TCF7L2 CEACAM5 MECOM PLXND1 FOXA1 LGR5 ZFPM2 ESRP2 DACT1 JUNB PIK3C2A AMOT GLI1 AHR LRP6 GAB1 SMAD2 CCDC40 | 5.32e-04 | 1125 | 150 | 19 | GO:0035239 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 5.43e-04 | 139 | 150 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 5.55e-04 | 52 | 150 | 4 | GO:0071526 | |
| GeneOntologyBiologicalProcess | epidermis development | 5.67e-04 | 461 | 150 | 11 | GO:0008544 | |
| GeneOntologyBiologicalProcess | organelle assembly | RABEP2 VPS37C ATXN2L KIAA0319L PUM2 DAZAP2 PTPN23 TOGARAM1 TSG101 RSPH6A STAM CSMD2 YTHDF1 LDB3 TNRC6A DNAH5 ULK2 DYNC1H1 CCDC40 | 6.12e-04 | 1138 | 150 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FOXS1 TCF7L2 PSEN2 FOSB TBX21 SREBF1 TSG101 BCOR FOXA1 ATXN1L TENM2 ZFPM2 DACT1 ATXN1 EGR1 AHR TAF1 PRDM16 | 6.54e-04 | 1053 | 150 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | dorsal/ventral neural tube patterning | 7.71e-04 | 25 | 150 | 3 | GO:0021904 | |
| GeneOntologyBiologicalProcess | regulation of extracellular exosome assembly | 7.73e-04 | 6 | 150 | 2 | GO:1903551 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 8.13e-04 | 207 | 150 | 7 | GO:0043484 | |
| GeneOntologyCellularComponent | chromatin | FOXS1 SETD1A TCF7L2 A1CF SPIB FOSB POLR2A TBX21 SREBF1 MEIS3 IRX6 KMT2E FOXA1 ZFPM2 HOXA3 TAF6L JUNB DMRT2 EGR1 ZMIZ2 AHR NR5A1 TAF1 PAX7 TCF7L1 SMAD2 | 2.63e-05 | 1480 | 153 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.04e-04 | 13 | 153 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | MAP1A SAXO2 TOGARAM1 RSPH6A NETO1 GLI1 ARC DNAH5 DYNC1H1 CCDC40 | 1.18e-04 | 317 | 153 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | cytoplasmic region | MAP1A SAXO2 TOGARAM1 RSPH6A NETO1 GLI1 ARC DNAH5 DYNC1H1 CCDC40 | 3.29e-04 | 360 | 153 | 10 | GO:0099568 |
| MousePheno | abnormal forebrain morphology | PLXNA3 ATXN2L ROBO4 DMXL2 TCF7L2 EIF4H MECOM TOGARAM1 STAM BCOR CSMD3 ATXN1L SSPOP TENM2 CRMP1 YTHDF1 JUNB DLGAP3 KMT2D EGR1 LRP6 NR5A1 DNAH5 TCF7L1 DYNC1H1 SEC23A SMAD2 | 9.54e-07 | 1072 | 127 | 27 | MP:0000783 |
| Domain | SET | 1.74e-06 | 46 | 150 | 6 | SM00317 | |
| Domain | SET_dom | 2.88e-06 | 50 | 150 | 6 | IPR001214 | |
| Domain | SET | 2.88e-06 | 50 | 150 | 6 | PS50280 | |
| Domain | Post-SET_dom | 6.75e-06 | 16 | 150 | 4 | IPR003616 | |
| Domain | PostSET | 6.75e-06 | 16 | 150 | 4 | SM00508 | |
| Domain | POST_SET | 6.75e-06 | 16 | 150 | 4 | PS50868 | |
| Domain | RRM | SETD1A RBPMS A1CF EIF4H ESRP2 RBM27 RBMS3 TNRC6A RBFOX2 RBM38 | 1.04e-05 | 217 | 150 | 10 | SM00360 |
| Domain | RRM_dom | SETD1A RBPMS A1CF EIF4H ESRP2 RBM27 RBMS3 TNRC6A RBFOX2 RBM38 | 1.53e-05 | 227 | 150 | 10 | IPR000504 |
| Domain | RRM | SETD1A RBPMS A1CF EIF4H ESRP2 RBM27 RBMS3 TNRC6A RBFOX2 RBM38 | 1.72e-05 | 230 | 150 | 10 | PS50102 |
| Domain | SET | 1.86e-05 | 41 | 150 | 5 | PF00856 | |
| Domain | - | SETD1A RBPMS A1CF EIF4H ESRP2 RBM27 RBMS3 TNRC6A RBFOX2 RBM38 | 2.85e-05 | 244 | 150 | 10 | 3.30.70.330 |
| Domain | Plexin_cytopl | 4.12e-05 | 9 | 150 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 4.12e-05 | 9 | 150 | 3 | IPR013548 | |
| Domain | Plexin | 4.12e-05 | 9 | 150 | 3 | IPR031148 | |
| Domain | Nucleotide-bd_a/b_plait | SETD1A RBPMS A1CF EIF4H ESRP2 RBM27 RBMS3 TNRC6A RBFOX2 RBM38 | 4.57e-05 | 258 | 150 | 10 | IPR012677 |
| Domain | RRM_1 | 4.75e-05 | 208 | 150 | 9 | PF00076 | |
| Domain | Evi1/Prdm16 | 6.41e-05 | 2 | 150 | 2 | IPR030413 | |
| Domain | RNA_pol_Rpb1_R | 6.41e-05 | 2 | 150 | 2 | PF05001 | |
| Domain | RNA_pol_II_repeat_euk | 6.41e-05 | 2 | 150 | 2 | IPR000684 | |
| Domain | AXH | 1.91e-04 | 3 | 150 | 2 | SM00536 | |
| Domain | AXH | 1.91e-04 | 3 | 150 | 2 | PF08517 | |
| Domain | Ataxin_AXH_dom | 1.91e-04 | 3 | 150 | 2 | IPR003652 | |
| Domain | AXH | 1.91e-04 | 3 | 150 | 2 | PS51148 | |
| Domain | LDLR_class-A_CS | 2.92e-04 | 40 | 150 | 4 | IPR023415 | |
| Domain | CTNNB1_binding | 3.80e-04 | 4 | 150 | 2 | PF08347 | |
| Domain | TCF/LEF | 3.80e-04 | 4 | 150 | 2 | IPR024940 | |
| Domain | CTNNB1-bd_N | 3.80e-04 | 4 | 150 | 2 | IPR013558 | |
| Domain | Ldl_recept_a | 4.61e-04 | 45 | 150 | 4 | PF00057 | |
| Domain | - | 5.02e-04 | 46 | 150 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.91e-04 | 48 | 150 | 4 | PS01209 | |
| Domain | FYrich_C | 6.31e-04 | 5 | 150 | 2 | IPR003889 | |
| Domain | FYrich_N | 6.31e-04 | 5 | 150 | 2 | IPR003888 | |
| Domain | FYRC | 6.31e-04 | 5 | 150 | 2 | SM00542 | |
| Domain | FYRN | 6.31e-04 | 5 | 150 | 2 | SM00541 | |
| Domain | FYRN | 6.31e-04 | 5 | 150 | 2 | PF05964 | |
| Domain | FYRC | 6.31e-04 | 5 | 150 | 2 | PF05965 | |
| Domain | FYRC | 6.31e-04 | 5 | 150 | 2 | PS51543 | |
| Domain | FYRN | 6.31e-04 | 5 | 150 | 2 | PS51542 | |
| Domain | CUB | 6.39e-04 | 49 | 150 | 4 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 6.39e-04 | 49 | 150 | 4 | IPR002172 | |
| Domain | LDLa | 6.39e-04 | 49 | 150 | 4 | SM00192 | |
| Domain | LDLRA_2 | 6.39e-04 | 49 | 150 | 4 | PS50068 | |
| Domain | CUB | 6.91e-04 | 50 | 150 | 4 | SM00042 | |
| Domain | - | 8.02e-04 | 52 | 150 | 4 | 2.60.120.290 | |
| Domain | CUB | 8.62e-04 | 53 | 150 | 4 | PS01180 | |
| Domain | HMG_box | 8.62e-04 | 53 | 150 | 4 | PF00505 | |
| Domain | HMG | 9.25e-04 | 54 | 150 | 4 | SM00398 | |
| Domain | CUB_dom | 1.13e-03 | 57 | 150 | 4 | IPR000859 | |
| Domain | IPT | 1.29e-03 | 27 | 150 | 3 | SM00429 | |
| Domain | DHC_N1 | 1.74e-03 | 8 | 150 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.74e-03 | 8 | 150 | 2 | IPR013594 | |
| Domain | HMG_box_dom | 1.85e-03 | 65 | 150 | 4 | IPR009071 | |
| Domain | Semap_dom | 1.94e-03 | 31 | 150 | 3 | IPR001627 | |
| Domain | SEMA | 1.94e-03 | 31 | 150 | 3 | PS51004 | |
| Domain | TIG | 1.94e-03 | 31 | 150 | 3 | PF01833 | |
| Domain | Sema | 1.94e-03 | 31 | 150 | 3 | SM00630 | |
| Domain | Sema | 1.94e-03 | 31 | 150 | 3 | PF01403 | |
| Domain | IPT | 2.12e-03 | 32 | 150 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 2.12e-03 | 32 | 150 | 3 | IPR002165 | |
| Domain | PSI | 2.12e-03 | 32 | 150 | 3 | PF01437 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.40e-05 | 39 | 113 | 5 | M29793 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.01e-05 | 70 | 113 | 6 | M27231 | |
| Pathway | WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES | 9.10e-05 | 57 | 113 | 5 | M39877 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.26e-04 | 61 | 113 | 5 | M152 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 1.71e-04 | 65 | 113 | 5 | M39374 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.13e-04 | 15 | 113 | 3 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.60e-04 | 16 | 113 | 3 | M8245 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 SETD1A TCF7L2 SCAMP4 MAP1A BEAN1 GTSE1 CNKSR2 TSG101 BCAR1 KMT2E LDLRAD3 EGR1 ZMIZ2 IGSF9B PAX7 DYNC1H1 GAB1 | 9.07e-13 | 430 | 154 | 18 | 35044719 |
| Pubmed | SETD1A MRPL21 TCF7L2 PUM2 MECOM MORC4 BCOR FOXA1 ATXN1L ZNF768 ZFPM2 YTHDF1 TAF6L KMT2C JUNB KMT2D FAM120A ATXN1 RBM27 ZMIZ2 TNRC6A LRP6 TAF1 QSER1 PAX7 SMAP2 PRDM16 HSPA4 DYNC1H1 ZMYM4 | 1.08e-12 | 1429 | 154 | 30 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A TCF7L2 NAB2 MECOM MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 ZMIZ2 TAF1 QSER1 PRDM16 ZMYM4 | 5.90e-11 | 351 | 154 | 15 | 38297188 |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 8.83e-11 | 8 | 154 | 5 | 23130995 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 SETD1A MRPL21 POLR2A GTSE1 KIAA0319L SREBF1 AKNA PLXND1 EXTL3 ESRP2 DACT1 KMT2C JUNB KMT2D ZNF341 GLI1 ZMIZ2 ARC PRDM16 ULK2 PLXNA1 DYNC1H1 RBM38 | 1.32e-10 | 1105 | 154 | 24 | 35748872 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXS1 POLR2A TBX21 NAB2 ASH1L SREBF1 DAZAP2 TSG101 MEIS3 IRX6 EYA2 FOXA1 ZNF768 HOXA3 JUNB EGR1 GLI1 AHR NR5A1 RBFOX2 SMAD2 | 3.72e-10 | 877 | 154 | 21 | 20211142 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXS1 TCF7L2 FOSB TBX21 ASH1L SREBF1 AKNA MEIS3 IRX6 FOXA1 ZFPM2 HOXA3 JUNB KMT2D DMRT2 EGR1 GLI1 NR5A1 PAX7 TCF7L1 SMAD2 | 6.94e-10 | 908 | 154 | 21 | 19274049 |
| Pubmed | PLXNA3 TCF7L2 EIF4H TBX21 SREBF1 MEIS3 IRX6 FOXA1 KMT2C LSR LDB3 GLI1 ZMIZ2 AHR PAX7 PRDM16 TCF7L1 PLXNA1 | 2.99e-09 | 709 | 154 | 18 | 22988430 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | VPS37C ATXN2L SETD1A SFSWAP EIF4H POLR2A BAG4 PUM2 MECOM TSG101 BCAR1 BCOR YTHDF1 JUNB LSR AMOT HSPA4 SEC23A RBM38 | 3.02e-08 | 922 | 154 | 19 | 27609421 |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 22431919 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SECISBP2L ATXN2L MRPL21 EIF4H POLR2A BAG4 PUM2 ZNF768 YTHDF1 ESRP2 HEATR6 FAM120A RBM27 TNRC6A DYNC1H1 RBFOX2 RBM38 | 1.24e-07 | 807 | 154 | 17 | 22681889 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.46e-07 | 184 | 154 | 9 | 32908313 | |
| Pubmed | 2.06e-07 | 57 | 154 | 6 | 18022353 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.47e-07 | 31 | 154 | 5 | 20516061 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXS1 MRPL21 FOSB POLR2A GTSE1 FRMPD1 MECOM FOXA1 ESRP2 JUNB KMT2D FAM120A GLI1 QSER1 DYNC1H1 ZMYM4 SMAD2 | 2.89e-07 | 857 | 154 | 17 | 25609649 |
| Pubmed | WIPF1 MAP1A PTPN23 SORBS1 EXTL3 KMT2C ATXN1 EGR1 TNRC6A TAF1 TNS1 GAB1 RBFOX2 | 2.89e-07 | 486 | 154 | 13 | 20936779 | |
| Pubmed | RABEP2 DMXL2 TRIOBP CNKSR2 SORBS1 BCOR TENM2 CRMP1 DLGAP3 FAM120A NETO1 ARC PLCL1 QSER1 TNS1 KCNT1 DYNC1H1 SEC23A | 3.01e-07 | 963 | 154 | 18 | 28671696 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 21436631 | ||
| Pubmed | 3.62e-07 | 268 | 154 | 10 | 33640491 | ||
| Pubmed | DMXL2 WIPF1 SORBS1 KMT2E DACT1 FAM120A PIK3C2A ATXN1 AMOT TAF1 PAX7 ZMYM4 SMAD2 | 3.72e-07 | 497 | 154 | 13 | 23414517 | |
| Pubmed | SFSWAP MAP1A POLR2A BAG4 ASH1L MECOM TSG101 BCOR FOXA1 ZNF768 TAF6L NAA35 FAM120A ATXN1 TNRC6A AHR TAF1 PRDM16 TCF7L1 | 5.67e-07 | 1116 | 154 | 19 | 31753913 | |
| Pubmed | IL34 ATXN2L RBPMS SREBF1 DAZAP2 BCOR ATXN1L SSPOP ZFPM2 TAF6L ATXN1 TAF1 HSPA4 RBFOX2 | 6.00e-07 | 608 | 154 | 14 | 16713569 | |
| Pubmed | SETD1A AKNA TRIOBP DAZAP2 PLXND1 BCOR KMT2C AFAP1 RBM27 AMOT TNRC6A KCNT1 ZMYM4 | 7.50e-07 | 529 | 154 | 13 | 14621295 | |
| Pubmed | 7.95e-07 | 225 | 154 | 9 | 12168954 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 21828091 | ||
| Pubmed | Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. | 8.46e-07 | 5 | 154 | 3 | 22939622 | |
| Pubmed | ATXN2L SETD1A POLR2A PTPN23 BCOR KMT2C KMT2D RBM27 AMOT TAF1 QSER1 DYNC1H1 ZMYM4 | 1.13e-06 | 549 | 154 | 13 | 38280479 | |
| Pubmed | 1.51e-06 | 44 | 154 | 5 | 27505670 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 1.69e-06 | 6 | 154 | 3 | 19304756 | |
| Pubmed | 1.69e-06 | 20 | 154 | 4 | 33431871 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TCF7L2 MECOM MORC4 BCOR ZFPM2 KMT2C KMT2D ZMIZ2 TAF1 PRDM16 SEC23A | 1.79e-06 | 398 | 154 | 11 | 35016035 |
| Pubmed | ATXN2L TCF7L2 WIPF1 EIF4H NAB2 BCOR ATXN1L KMT2C JUNB KMT2D FAM120A EGR1 RBM27 ZMIZ2 QSER1 HSPA4 DYNC1H1 ZMYM4 | 2.09e-06 | 1103 | 154 | 18 | 34189442 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 2.54e-06 | 22 | 154 | 4 | 26886794 | |
| Pubmed | 2.54e-06 | 22 | 154 | 4 | 21775418 | ||
| Pubmed | 2.71e-06 | 335 | 154 | 10 | 15741177 | ||
| Pubmed | Smads bind directly to the Jun family of AP-1 transcription factors. | 2.94e-06 | 7 | 154 | 3 | 10220381 | |
| Pubmed | PLXNA3 TCF7L2 FOSB ASH1L SREBF1 JUNB LSR ATXN1 EGR1 ZMIZ2 AHR PRDM16 TCF7L1 PLXNA1 SMAD2 | 3.37e-06 | 808 | 154 | 15 | 20412781 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 4.22e-06 | 146 | 154 | 7 | 23892456 | |
| Pubmed | RBPMS SFSWAP EIF4H POLR2A GTSE1 BAG4 PUM2 RPRD1B YTHDF1 FAM120A RBMS3 TNRC6A RBFOX2 RBM38 | 4.50e-06 | 723 | 154 | 14 | 34133714 | |
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 21177349 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 22266653 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 37548402 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.92e-06 | 281 | 154 | 9 | 28706196 | |
| Pubmed | PLXNA3 SETD1A DMXL2 CEACAM5 POLR2A PLXND1 KMT2E GGT5 PLCL1 TAF1 DNAH5 ULK2 PLXNA1 SEC23A | 5.02e-06 | 730 | 154 | 14 | 34857952 | |
| Pubmed | 5.50e-06 | 152 | 154 | 7 | 38360978 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MXRA5 PCDHGB3 POLR2A ROR1 CSMD2 ATXN1L SSPOP ESRP2 TAF6L KMT2C AMOT AHR IGSF9B DYNC1H1 | 5.51e-06 | 736 | 154 | 14 | 29676528 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TCF7L2 PUM2 BCOR YTHDF1 KMT2C KMT2D PIK3C2A RBM27 GLI1 TNRC6A QSER1 | 6.67e-06 | 457 | 154 | 11 | 32344865 |
| Pubmed | 7.01e-06 | 9 | 154 | 3 | 22665483 | ||
| Pubmed | UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. | 7.01e-06 | 9 | 154 | 3 | 21757351 | |
| Pubmed | 7.01e-06 | 9 | 154 | 3 | 26456826 | ||
| Pubmed | 9.99e-06 | 10 | 154 | 3 | 19842175 | ||
| Pubmed | A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. | 9.99e-06 | 10 | 154 | 3 | 22393260 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.66e-05 | 180 | 154 | 7 | 35198878 | |
| Pubmed | PLEKHB2 DMXL2 KIAA0319L ASH1L TRIOBP DAZAP2 TSG101 SORBS1 EXTL3 STAM CRMP1 HEATR6 FAM120A NETO1 TAF1 DYNC1H1 ZMYM4 SMAD2 | 1.67e-05 | 1285 | 154 | 18 | 35914814 | |
| Pubmed | 1.73e-05 | 251 | 154 | 8 | 27507650 | ||
| Pubmed | 1.82e-05 | 12 | 154 | 3 | 27563068 | ||
| Pubmed | 1.82e-05 | 12 | 154 | 3 | 25839327 | ||
| Pubmed | 1.82e-05 | 12 | 154 | 3 | 1797234 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.82e-05 | 12 | 154 | 3 | 21270798 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28790171 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 29466757 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26517531 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11050005 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11135623 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9087448 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17322884 | ||
| Pubmed | SMAD2 promotes myogenin expression and terminal myogenic differentiation. | 1.95e-05 | 2 | 154 | 2 | 33462116 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23413876 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 31924266 | ||
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 1.95e-05 | 2 | 154 | 2 | 1741298 | |
| Pubmed | High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. | 1.95e-05 | 2 | 154 | 2 | 25567132 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 39062853 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28967912 | ||
| Pubmed | The expansion of human T-bethighCD21low B cells is T cell dependent. | 1.95e-05 | 2 | 154 | 2 | 34623902 | |
| Pubmed | The Immediate Early Response of Lens Epithelial Cells to Lens Injury. | 1.95e-05 | 2 | 154 | 2 | 36359852 | |
| Pubmed | FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway. | 1.95e-05 | 2 | 154 | 2 | 37890593 | |
| Pubmed | CREPT is required for murine stem cell maintenance during intestinal regeneration. | 1.95e-05 | 2 | 154 | 2 | 33431892 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34755534 | ||
| Pubmed | T-bet expression is regulated by EGR1-mediated signaling in activated T cells. | 1.95e-05 | 2 | 154 | 2 | 19307156 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 36601880 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 28483418 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30557604 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 1.95e-05 | 2 | 154 | 2 | 34156443 | |
| Pubmed | Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins. | 1.95e-05 | 2 | 154 | 2 | 31054975 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16260776 | ||
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 1.95e-05 | 2 | 154 | 2 | 9916915 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27280393 | ||
| Pubmed | Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. | 1.95e-05 | 2 | 154 | 2 | 18496560 | |
| Pubmed | NAB2 and EGR-1 exert opposite roles in regulating TRAIL expression in human Natural Killer cells. | 1.95e-05 | 2 | 154 | 2 | 23416169 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 36869380 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 37595559 | ||
| Pubmed | TCF7L1 Regulates LGR5 Expression in Colorectal Cancer Cells. | 1.95e-05 | 2 | 154 | 2 | 36833408 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25346535 | ||
| Pubmed | Altered expression of MLL methyltransferase family genes in breast cancer. | 1.95e-05 | 2 | 154 | 2 | 23754336 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 16109773 | ||
| Pubmed | ATXN2L DMXL2 MAP1A CNKSR2 TSG101 SORBS1 CRMP1 DLGAP3 AFAP1 FAM120A AMOT AJM1 SYNGR1 PLCL1 TNS1 PLPPR2 HSPA4 DYNC1H1 SEC23A | 2.02e-05 | 1431 | 154 | 19 | 37142655 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L EIF4H MAP1A TRIOBP PUM2 YTHDF1 FAM120A PIK3C2A RBM27 RBMS3 AMOT TNRC6A SMAP2 | 2.21e-05 | 724 | 154 | 13 | 36232890 |
| Pubmed | 2.29e-05 | 261 | 154 | 8 | 33277362 | ||
| Pubmed | 2.36e-05 | 13 | 154 | 3 | 21502505 | ||
| Pubmed | The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3. | 2.36e-05 | 13 | 154 | 3 | 27313319 | |
| Interaction | GSC interactions | TCF7L2 TBX21 MECOM MORC4 ATXN1L KMT2C KMT2D ATXN1 QSER1 PRDM16 SMAD2 | 6.15e-11 | 87 | 154 | 11 | int:GSC |
| Interaction | EGR2 interactions | TCF7L2 NAB2 MECOM MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 ZMIZ2 QSER1 PRDM16 ZMYM4 | 6.93e-10 | 171 | 154 | 13 | int:EGR2 |
| Interaction | CRX interactions | VPS37C TCF7L2 RBPMS MECOM IRX6 MORC4 ATXN1L KMT2C KMT2D ATXN1 ZMIZ2 QSER1 SMAP2 PRDM16 ZMYM4 | 1.10e-09 | 254 | 154 | 15 | int:CRX |
| Interaction | PAX9 interactions | VPS37C TBX21 EYA2 MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 ZMIZ2 QSER1 | 4.82e-09 | 130 | 154 | 11 | int:PAX9 |
| Interaction | ALG13 interactions | TCF7L2 RBPMS BAG4 PUM2 BCOR ATXN1L YTHDF1 KMT2D FAM120A TNRC6A SMAP2 RBFOX2 | 1.71e-08 | 183 | 154 | 12 | int:ALG13 |
| Interaction | RBFOX2 interactions | RBPMS BAG4 PUM2 DAZAP2 MECOM BCOR ATXN1L YTHDF1 ESRP2 FAM120A ATXN1 TNRC6A RBFOX2 RBM38 | 4.00e-08 | 284 | 154 | 14 | int:RBFOX2 |
| Interaction | FEV interactions | SETD1A TCF7L2 MECOM MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 TAF1 QSER1 ZMYM4 | 5.40e-08 | 203 | 154 | 12 | int:FEV |
| Interaction | RBPMS interactions | FOXS1 VPS37C TCF7L2 RBPMS NAB2 BAG4 DAZAP2 TSG101 EYA2 FOXA1 ATXN1L YTHDF1 FAM120A ATXN1 RBFOX2 | 5.55e-08 | 340 | 154 | 15 | int:RBPMS |
| Interaction | FAM168A interactions | PLEKHB2 VPS37C RBPMS POLR2A DAZAP2 ATXN1L YTHDF1 ATXN1 AMOT SMAP2 | 1.42e-07 | 142 | 154 | 10 | int:FAM168A |
| Interaction | KLF3 interactions | SETD1A TCF7L2 MECOM MORC4 BCOR ATXN1L KMT2D ATXN1 TAF1 QSER1 PRDM16 ZMYM4 | 1.92e-07 | 228 | 154 | 12 | int:KLF3 |
| Interaction | TBR1 interactions | 2.13e-07 | 113 | 154 | 9 | int:TBR1 | |
| Interaction | TBXT interactions | 2.67e-07 | 116 | 154 | 9 | int:TBXT | |
| Interaction | TLE5 interactions | VPS37C TCF7L2 RBPMS FOSB NAB2 BAG4 DAZAP2 MECOM MEIS3 IRX6 EYA2 ATXN1L YTHDF1 MFAP4 DMRT2 PAX7 | 3.02e-07 | 443 | 154 | 16 | int:TLE5 |
| Interaction | KLF5 interactions | TCF7L2 SREBF1 MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 QSER1 ZMYM4 SMAD2 | 3.16e-07 | 195 | 154 | 11 | int:KLF5 |
| Interaction | ELK3 interactions | 3.57e-07 | 120 | 154 | 9 | int:ELK3 | |
| Interaction | GATA2 interactions | TCF7L2 RBPMS MORC4 BCOR ATXN1L ZFPM2 KMT2C KMT2D ATXN1 QSER1 ADAMTSL4 | 3.88e-07 | 199 | 154 | 11 | int:GATA2 |
| Interaction | GCM1 interactions | 8.71e-07 | 68 | 154 | 7 | int:GCM1 | |
| Interaction | PRRC2B interactions | RBPMS BAG4 PUM2 EYA2 BCOR ATXN1L YTHDF1 FAM120A ATXN1 TNRC6A SMAP2 RBFOX2 | 9.54e-07 | 265 | 154 | 12 | int:PRRC2B |
| Interaction | TLE3 interactions | TCF7L2 NAB2 STAM EYA2 BCOR FOXA1 ATXN1L MFAP4 KMT2D ATXN1 EGR1 ZMIZ2 TNRC6A PAX7 | 1.21e-06 | 376 | 154 | 14 | int:TLE3 |
| Interaction | C1orf94 interactions | 1.25e-06 | 103 | 154 | 8 | int:C1orf94 | |
| Interaction | VPS37C interactions | 1.39e-06 | 141 | 154 | 9 | int:VPS37C | |
| Interaction | NFIX interactions | SETD1A TCF7L2 BCOR FOXA1 ATXN1L KMT2C KMT2D ATXN1 QSER1 PAX7 ZMYM4 | 1.42e-06 | 227 | 154 | 11 | int:NFIX |
| Interaction | TCF7L1 interactions | 1.55e-06 | 12 | 154 | 4 | int:TCF7L1 | |
| Interaction | DAZAP2 interactions | PLEKHB2 VPS37C TCF7L2 RBPMS DAZAP2 ATXN1L ATXN1 SMAP2 TCF7L1 RBFOX2 | 1.71e-06 | 186 | 154 | 10 | int:DAZAP2 |
| Interaction | DAZL interactions | SECISBP2L ATXN2L PUM2 DAZAP2 YTHDF1 FAM120A RBMS3 TNRC6A SMAP2 | 1.76e-06 | 145 | 154 | 9 | int:DAZL |
| Interaction | TOP3B interactions | PLXNA3 SETD1A MRPL21 POLR2A GTSE1 KIAA0319L SREBF1 AKNA PLXND1 EXTL3 YTHDF1 ESRP2 DACT1 KMT2C JUNB KMT2D FAM120A ZNF341 GLI1 ZMIZ2 ARC SMAP2 PRDM16 ULK2 ADAMTSL4 PLXNA1 DYNC1H1 SEC23A RBM38 | 2.01e-06 | 1470 | 154 | 29 | int:TOP3B |
| Interaction | HNF1B interactions | 2.08e-06 | 190 | 154 | 10 | int:HNF1B | |
| Interaction | HNF1A interactions | 2.64e-06 | 80 | 154 | 7 | int:HNF1A | |
| Interaction | SOX7 interactions | 3.12e-06 | 82 | 154 | 7 | int:SOX7 | |
| Interaction | EIF4ENIF1 interactions | POLR2A BAG4 PUM2 RPRD1B YTHDF1 FAM120A ATXN1 TNRC6A TAF1 SMAP2 RBFOX2 SMAD2 | 3.47e-06 | 300 | 154 | 12 | int:EIF4ENIF1 |
| Interaction | IRF4 interactions | 3.98e-06 | 85 | 154 | 7 | int:IRF4 | |
| Interaction | PTPN23 interactions | 4.39e-06 | 162 | 154 | 9 | int:PTPN23 | |
| Interaction | RBMS1 interactions | SECISBP2L ATXN2L PUM2 FOXA1 YTHDF1 ESRP2 FAM120A TNRC6A SMAP2 RBFOX2 | 4.47e-06 | 207 | 154 | 10 | int:RBMS1 |
| Interaction | PAX7 interactions | 5.04e-06 | 124 | 154 | 8 | int:PAX7 | |
| Interaction | SEC16A interactions | GTSE1 PTPN23 TSG101 EYA2 BCOR FOXA1 FAM120A PIK3C2A AMOT TNRC6A KDF1 SMAP2 ULK2 SEC23A | 5.15e-06 | 426 | 154 | 14 | int:SEC16A |
| Interaction | ATXN2 interactions | ATXN2L RBPMS PTPN23 TSG101 YTHDF1 NAA35 FAM120A ATXN1 GMDS KDF1 SMAP2 RBFOX2 | 5.18e-06 | 312 | 154 | 12 | int:ATXN2 |
| Interaction | UBAP2 interactions | 6.50e-06 | 170 | 154 | 9 | int:UBAP2 | |
| Interaction | AR interactions | TCF7L2 SREBF1 TSG101 MORC4 BCOR FOXA1 ATXN1L RPRD1B TAF6L KMT2C KMT2D ATXN1 RBM27 ZMIZ2 AHR NR5A1 TAF1 QSER1 TNS1 HSPA4 DYNC1H1 ZMYM4 | 6.73e-06 | 992 | 154 | 22 | int:AR |
| Interaction | R3HDM2 interactions | 6.76e-06 | 129 | 154 | 8 | int:R3HDM2 | |
| Interaction | DMRTB1 interactions | 7.79e-06 | 94 | 154 | 7 | int:DMRTB1 | |
| Interaction | PIN1 interactions | RBPMS POLR2A NAB2 EYA2 ZNF768 RPRD1B EGR1 AMOT GLI1 ZMIZ2 NR5A1 ADAMTSL4 SMAD2 | 8.04e-06 | 383 | 154 | 13 | int:PIN1 |
| Interaction | ERG interactions | TCF7L2 POLR2A MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 QSER1 HSPA4 | 8.62e-06 | 223 | 154 | 10 | int:ERG |
| Interaction | FHL2 interactions | ATXN2L SETD1A A1CF PSEN2 SAXO2 MORC4 ATXN1 RBM27 AMOT AHR QSER1 ZMYM4 SMAD2 | 1.15e-05 | 396 | 154 | 13 | int:FHL2 |
| Interaction | TNIP2 interactions | VPS37C ATXN2L SETD1A SFSWAP EIF4H POLR2A BAG4 PUM2 MECOM TSG101 BCAR1 BCOR YTHDF1 JUNB LSR AMOT TNRC6A HSPA4 SEC23A RBM38 CCDC40 | 1.21e-05 | 952 | 154 | 21 | int:TNIP2 |
| Interaction | NFIA interactions | 1.46e-05 | 188 | 154 | 9 | int:NFIA | |
| Interaction | CREBBP interactions | SETD1A TCF7L2 SPIB FOSB POLR2A TBX21 SREBF1 MECOM TAF6L JUNB KMT2D ATXN1 EGR1 NR5A1 PAX7 SMAD2 | 1.46e-05 | 599 | 154 | 16 | int:CREBBP |
| Interaction | UNK interactions | ATXN2L EIF4H POLR2A PUM2 STAM BCAR1 YTHDF1 ATXN1 TNRC6A SMAP2 HSPA4 DYNC1H1 RBFOX2 | 1.57e-05 | 408 | 154 | 13 | int:UNK |
| Interaction | QKI interactions | 1.59e-05 | 190 | 154 | 9 | int:QKI | |
| Interaction | LARP4B interactions | SECISBP2L RBPMS PUM2 BCAR1 ATXN1L YTHDF1 FAM120A ATXN1 SMAP2 RBFOX2 | 1.63e-05 | 240 | 154 | 10 | int:LARP4B |
| Interaction | SEC24B interactions | MAN2A1 GTSE1 TSG101 STAM BCAR1 TNRC6A QSER1 KDF1 SMAP2 SEC23A | 1.63e-05 | 240 | 154 | 10 | int:SEC24B |
| Interaction | UBAP2L interactions | ATXN2L PUM2 BCOR YTHDF1 ESRP2 FAM120A DMRT2 PIK3C2A ATXN1 TNRC6A SMAP2 | 1.90e-05 | 298 | 154 | 11 | int:UBAP2L |
| Interaction | ATXN1L interactions | 2.04e-05 | 150 | 154 | 8 | int:ATXN1L | |
| Interaction | EN1 interactions | 2.19e-05 | 110 | 154 | 7 | int:EN1 | |
| Interaction | PAX8 interactions | 2.32e-05 | 111 | 154 | 7 | int:PAX8 | |
| Interaction | RBM47 interactions | 2.79e-05 | 204 | 154 | 9 | int:RBM47 | |
| Interaction | SOX6 interactions | 2.83e-05 | 157 | 154 | 8 | int:SOX6 | |
| Interaction | NUMBL interactions | 3.08e-05 | 116 | 154 | 7 | int:NUMBL | |
| Interaction | KRTAP19-7 interactions | 3.26e-05 | 117 | 154 | 7 | int:KRTAP19-7 | |
| Interaction | CLASRP interactions | 3.41e-05 | 80 | 154 | 6 | int:CLASRP | |
| Interaction | EPN1 interactions | 3.44e-05 | 118 | 154 | 7 | int:EPN1 | |
| Interaction | NFIC interactions | 3.51e-05 | 210 | 154 | 9 | int:NFIC | |
| Interaction | ZNF34 interactions | 3.55e-05 | 49 | 154 | 5 | int:ZNF34 | |
| Interaction | PICALM interactions | RBPMS ROR1 GTSE1 PTPN23 ATXN1L PIK3C2A ATXN1 TNRC6A SMAP2 RBM38 | 3.57e-05 | 263 | 154 | 10 | int:PICALM |
| Interaction | ASH2L interactions | 3.81e-05 | 265 | 154 | 10 | int:ASH2L | |
| Interaction | PAX2 interactions | 4.80e-05 | 85 | 154 | 6 | int:PAX2 | |
| Interaction | DTX2 interactions | RBPMS KIAA0319L DAZAP2 MECOM EYA2 BCOR ESRP2 LSR RBM27 TNRC6A SEC23A | 4.82e-05 | 330 | 154 | 11 | int:DTX2 |
| Interaction | HNF4A interactions | SETD1A TCF7L2 SREBF1 BCOR KMT2C KMT2D ATXN1 QSER1 ZMYM4 SMAD2 | 5.20e-05 | 275 | 154 | 10 | int:HNF4A |
| Interaction | GATA1 interactions | 5.20e-05 | 171 | 154 | 8 | int:GATA1 | |
| Interaction | CPSF7 interactions | ATXN2L RBPMS GTSE1 BAG4 TSG101 FOXA1 YTHDF1 ATXN1 TNRC6A RBFOX2 SMAD2 | 5.98e-05 | 338 | 154 | 11 | int:CPSF7 |
| Interaction | PUM1 interactions | ATXN2L PUM2 EYA2 YTHDF1 FAM120A ATXN1 TNRC6A KDF1 SMAP2 RBFOX2 | 7.42e-05 | 287 | 154 | 10 | int:PUM1 |
| Interaction | KMT2C interactions | 7.74e-05 | 134 | 154 | 7 | int:KMT2C | |
| Interaction | ZBTB32 interactions | 8.07e-05 | 58 | 154 | 5 | int:ZBTB32 | |
| Interaction | TLX3 interactions | 8.33e-05 | 291 | 154 | 10 | int:TLX3 | |
| Interaction | BAG2 interactions | SETD1A MECOM PTPN23 STAM BCOR FOXA1 RPRD1B ESRP2 PIK3C2A ATXN1 RBM27 AMOT QSER1 SMAP2 HSPA4 | 8.72e-05 | 622 | 154 | 15 | int:BAG2 |
| Interaction | BATF2 interactions | 8.79e-05 | 31 | 154 | 4 | int:BATF2 | |
| Interaction | LHX3 interactions | 9.04e-05 | 185 | 154 | 8 | int:LHX3 | |
| Interaction | YAP1 interactions | ATXN2L SETD1A SCAMP4 BEAN1 POLR2A BAG4 TRIOBP CNKSR2 FOXA1 KMT2C KMT2D FAM120A AMOT GLI1 IGSF9B TAF1 HSPA4 DYNC1H1 ZMYM4 GAB1 SMAD2 | 9.25e-05 | 1095 | 154 | 21 | int:YAP1 |
| Interaction | CLEC11A interactions | 9.50e-05 | 96 | 154 | 6 | int:CLEC11A | |
| Interaction | GATA3 interactions | 9.74e-05 | 187 | 154 | 8 | int:GATA3 | |
| Interaction | NUP35 interactions | TCF7L2 PUM2 BCAR1 BCOR YTHDF1 KMT2C KMT2D PIK3C2A RBM27 GLI1 TNRC6A QSER1 | 1.05e-04 | 424 | 154 | 12 | int:NUP35 |
| Interaction | SMAP2 interactions | 1.05e-04 | 189 | 154 | 8 | int:SMAP2 | |
| Interaction | GLI3 interactions | 1.07e-04 | 98 | 154 | 6 | int:GLI3 | |
| Interaction | EYA4 interactions | 1.08e-04 | 243 | 154 | 9 | int:EYA4 | |
| Interaction | NFIB interactions | 1.11e-04 | 142 | 154 | 7 | int:NFIB | |
| Interaction | YTHDF1 interactions | VPS37C RBPMS PUM2 YTHDF1 FAM120A RBMS3 TNRC6A SMAP2 PLPPR2 RBFOX2 | 1.13e-04 | 302 | 154 | 10 | int:YTHDF1 |
| Interaction | SP7 interactions | TCF7L2 MORC4 BCOR ATXN1L KMT2C KMT2D ATXN1 RBM27 ZMIZ2 QSER1 | 1.19e-04 | 304 | 154 | 10 | int:SP7 |
| Interaction | PRR20E interactions | 1.26e-04 | 101 | 154 | 6 | int:PRR20E | |
| Interaction | SYNGAP1 interactions | ATXN2L DMXL2 MAP1A CNKSR2 SORBS1 DLGAP3 ARC PLCL1 ULK2 DYNC1H1 | 1.29e-04 | 307 | 154 | 10 | int:SYNGAP1 |
| Interaction | FOXL1 interactions | 1.35e-04 | 196 | 154 | 8 | int:FOXL1 | |
| Interaction | STAM2 interactions | 1.38e-04 | 147 | 154 | 7 | int:STAM2 | |
| Interaction | ARID5A interactions | 1.38e-04 | 147 | 154 | 7 | int:ARID5A | |
| Interaction | PHIP interactions | 1.40e-04 | 197 | 154 | 8 | int:PHIP | |
| Interaction | TOPAZ1 interactions | 1.50e-04 | 14 | 154 | 3 | int:TOPAZ1 | |
| Interaction | METTL27 interactions | 1.60e-04 | 36 | 154 | 4 | int:METTL27 | |
| Interaction | SMG7 interactions | SECISBP2L MECOM MORC4 BCOR YTHDF1 KMT2D FAM120A AMOT TNRC6A SMAP2 | 1.76e-04 | 319 | 154 | 10 | int:SMG7 |
| Interaction | HGS interactions | PLEKHB2 VPS37C DAZAP2 PTPN23 TSG101 MEIS3 STAM EYA2 ATXN1L CRMP1 SMAP2 SEC23A SMAD2 | 1.95e-04 | 523 | 154 | 13 | int:HGS |
| Interaction | MGAT4C interactions | 1.98e-04 | 38 | 154 | 4 | int:MGAT4C | |
| Interaction | POGZ interactions | 2.07e-04 | 265 | 154 | 9 | int:POGZ | |
| Interaction | KLF8 interactions | SETD1A TCF7L2 MECOM BCOR ZNF768 KMT2D ATXN1 QSER1 HSPA4 ZMYM4 | 2.26e-04 | 329 | 154 | 10 | int:KLF8 |
| Interaction | CDKL5 interactions | 2.33e-04 | 113 | 154 | 6 | int:CDKL5 | |
| Cytoband | 1p35.3-p34.1 | 1.12e-05 | 2 | 154 | 2 | 1p35.3-p34.1 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.04e-10 | 34 | 104 | 7 | 487 | |
| GeneFamily | RNA binding motif containing | 3.85e-06 | 213 | 104 | 9 | 725 | |
| GeneFamily | Plexins | 1.51e-05 | 9 | 104 | 3 | 683 | |
| GeneFamily | ESCRT-I | 1.15e-03 | 9 | 104 | 2 | 1116 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.22e-03 | 206 | 104 | 6 | 682 | |
| GeneFamily | PHD finger proteins | 1.81e-03 | 90 | 104 | 4 | 88 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.38e-03 | 161 | 104 | 5 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.21e-03 | 17 | 104 | 2 | 1197 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.32e-03 | 57 | 104 | 3 | 1179 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOPC | GTSE1 EYA2 LGR5 CSMD3 SSPOP EGR1 NETO1 ARC IGSF9B TNS1 PLPPR2 GAB1 | 1.74e-06 | 366 | 153 | 12 | M39052 |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | MXRA5 RBPMS PSEN2 FOSB NAB2 SREBF1 FTSJ1 SORBS1 GGT5 JUNB EGR1 RBMS3 TNS1 TCF7L1 | 4.16e-06 | 546 | 153 | 14 | M3837 |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | PLXNA3 BAG4 ASH1L SREBF1 FTSJ1 EYA2 BCOR LGR5 CRMP1 MFAP4 TNRC6A PLPPR2 DCBLD2 RBM38 | 5.90e-06 | 563 | 153 | 14 | M15103 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.00e-05 | 84 | 153 | 6 | M13008 | |
| Coexpression | CHASSOT_SKIN_WOUND | 1.60e-05 | 9 | 153 | 3 | M13038 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.93e-05 | 194 | 153 | 8 | M39122 | |
| Coexpression | GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN | 2.00e-05 | 195 | 153 | 8 | M5765 | |
| Coexpression | NAGASHIMA_EGF_SIGNALING_UP | 2.08e-05 | 57 | 153 | 5 | M16311 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN | 2.40e-05 | 200 | 153 | 8 | M7305 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 2.40e-05 | 200 | 153 | 8 | M6047 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 3.64e-05 | 155 | 153 | 7 | M39246 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 4.29e-05 | 217 | 153 | 8 | M16407 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | PRUNE2 FMOD STON1 AKNA MECOM LDLRAD3 HOXA3 MFAP4 ATXN1 RBMS3 | 4.74e-05 | 355 | 153 | 10 | M45758 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 6.08e-05 | 228 | 153 | 8 | MM1014 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L PLXNA3 SORBS1 KMT2E CSMD2 LGR5 CSMD3 SSPOP TENM2 ZFPM2 CRMP1 DACT1 RBMS3 NETO1 TNRC6A IGSF9B PLXNA1 RBFOX2 | 8.43e-05 | 1106 | 153 | 18 | M39071 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | RBPMS FOSB NAB2 ASH1L EYA2 KMT2E FOXA1 CR2 LGR5 TENM2 HOXA3 JUNB NR5A1 ZMYM4 | 8.87e-05 | 721 | 153 | 14 | M1999 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | PLXNA3 CSMD3 TENM2 CRMP1 RBMS3 NETO1 PLCL1 SMAP2 PLPPR2 RBFOX2 | 1.01e-04 | 389 | 153 | 10 | M39073 |
| Coexpression | IL2_UP.V1_UP | 1.31e-04 | 190 | 153 | 7 | M2822 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 1.49e-04 | 194 | 153 | 7 | M8864 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L DMXL2 TCF7L2 RBPMS MAN2A1 ROR1 PUM2 MECOM TOGARAM1 STAM AFAP1 PIK3C2A ATXN1 ZMYM4 RBFOX2 | 1.54e-04 | 856 | 153 | 15 | M4500 |
| Coexpression | GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP | 1.59e-04 | 196 | 153 | 7 | M8428 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 1.74e-04 | 199 | 153 | 7 | M316 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP | 1.74e-04 | 199 | 153 | 7 | M8390 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP | 1.74e-04 | 199 | 153 | 7 | M3677 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | 1.74e-04 | 199 | 153 | 7 | M3846 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 1.74e-04 | 199 | 153 | 7 | M7374 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN | 1.80e-04 | 200 | 153 | 7 | M8398 | |
| Coexpression | GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP | 1.80e-04 | 200 | 153 | 7 | M3425 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 1.80e-04 | 200 | 153 | 7 | M7478 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | PRUNE2 DMXL2 PSEN2 MAP1A SORBS1 MEIS3 BCAR1 RPRD1B LDB3 ARC LIX1 RBM38 | 1.85e-04 | 589 | 153 | 12 | M45662 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | RBPMS FMOD STON1 WIPF1 MAP1A DACT1 MFAP4 AFAP1 ATXN1 AHR TNS1 DCBLD2 SEC23A | 1.88e-04 | 681 | 153 | 13 | M39175 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | ROBO4 MXRA5 RBPMS MEIS3 PLXND1 CSMD3 GGT5 DACT1 MFAP4 RBMS3 TNS1 | 1.95e-04 | 505 | 153 | 11 | M39167 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | TCF7L2 RBPMS EIF4H MAP1A POLR2A EYA2 GGT5 JUNB FAM120A ARC TNS1 HSPA4 TCF7L1 | 1.99e-04 | 685 | 153 | 13 | MM3782 |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC1 | 2.40e-04 | 21 | 153 | 3 | MM914 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC1 | 2.40e-04 | 21 | 153 | 3 | M2332 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | FOXS1 NAALADL1 MXRA5 RBPMS FOSB SORBS1 GGT5 DACT1 JUNB EGR1 RBMS3 PLCL1 TNS1 GAB1 | 2.44e-04 | 795 | 153 | 14 | M39050 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP | 2.66e-04 | 151 | 153 | 6 | M6760 | |
| Coexpression | TIAN_TNF_SIGNALING_NOT_VIA_NFKB | 2.77e-04 | 22 | 153 | 3 | M14666 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 3.02e-04 | 55 | 153 | 4 | MM397 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_UP | 3.06e-04 | 100 | 153 | 5 | M11028 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 3.06e-04 | 365 | 153 | 9 | M39018 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | PRUNE2 MXRA5 RBPMS SORBS1 DACT1 MFAP4 RBMS3 GLI1 TNS1 RBFOX2 | 1.50e-09 | 193 | 154 | 10 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.78e-09 | 173 | 154 | 9 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.42e-08 | 192 | 154 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.36e-07 | 190 | 154 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 194 | 154 | 8 | 8c6e5ba27a988e0cd6b8c25cb9a30a0da2b1f7f9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 194 | 154 | 8 | 5b29c843186c2394f5bec3b1d5ae284a0d931d85 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 194 | 154 | 8 | ebcf6c6d0eb20a5d422becf5a730089230c8ba9a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 194 | 154 | 8 | 6e78e3046c5b172af92a84e25f982377a0aaac58 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-07 | 195 | 154 | 8 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | COVID-19-Epithelial-AT2,_AT1_cells|COVID-19 / Condition, Lineage and Cell class | 4.60e-07 | 198 | 154 | 8 | 7e6f089e71e70190ff8486341ab06719d7741467 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-07 | 199 | 154 | 8 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-07 | 199 | 154 | 8 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-07 | 199 | 154 | 8 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.78e-07 | 199 | 154 | 8 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 159 | 154 | 7 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 159 | 154 | 7 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 170 | 154 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-06 | 171 | 154 | 7 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.93e-06 | 178 | 154 | 7 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.16e-06 | 180 | 154 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.16e-06 | 180 | 154 | 7 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 181 | 154 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 181 | 154 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 182 | 154 | 7 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 184 | 154 | 7 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 184 | 154 | 7 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.78e-06 | 185 | 154 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-06 | 185 | 154 | 7 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-06 | 185 | 154 | 7 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-06 | 186 | 154 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 187 | 154 | 7 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 4.06e-06 | 187 | 154 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 187 | 154 | 7 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-06 | 187 | 154 | 7 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.25e-06 | 122 | 154 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 4.25e-06 | 122 | 154 | 6 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 189 | 154 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 4.67e-06 | 191 | 154 | 7 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.67e-06 | 191 | 154 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.67e-06 | 191 | 154 | 7 | 4180521a8c5e0ad629cacdd22dc6a94e94b28816 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 191 | 154 | 7 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 191 | 154 | 7 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.83e-06 | 192 | 154 | 7 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 193 | 154 | 7 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.00e-06 | 193 | 154 | 7 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.00e-06 | 193 | 154 | 7 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.17e-06 | 194 | 154 | 7 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-06 | 195 | 154 | 7 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.53e-06 | 196 | 154 | 7 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 5.72e-06 | 197 | 154 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 5.72e-06 | 197 | 154 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-06 | 198 | 154 | 7 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-06 | 198 | 154 | 7 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-06 | 198 | 154 | 7 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-06 | 198 | 154 | 7 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.91e-06 | 198 | 154 | 7 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.91e-06 | 198 | 154 | 7 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-06 | 198 | 154 | 7 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.91e-06 | 198 | 154 | 7 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.91e-06 | 198 | 154 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-06 | 198 | 154 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.91e-06 | 198 | 154 | 7 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.91e-06 | 198 | 154 | 7 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 6.11e-06 | 199 | 154 | 7 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 6.11e-06 | 199 | 154 | 7 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.11e-06 | 199 | 154 | 7 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-06 | 200 | 154 | 7 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 6.31e-06 | 200 | 154 | 7 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-06 | 200 | 154 | 7 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 137 | 154 | 6 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 137 | 154 | 6 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.87e-05 | 158 | 154 | 6 | 4f3ea658e032555c2098d016475381c8d1071699 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 159 | 154 | 6 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.00e-05 | 160 | 154 | 6 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 166 | 154 | 6 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 166 | 154 | 6 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 166 | 154 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 167 | 154 | 6 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.64e-05 | 168 | 154 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.01e-05 | 172 | 154 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 173 | 154 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 173 | 154 | 6 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 173 | 154 | 6 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A | ATXN2L DMXL2 NAB2 KIAA0319L SREBF1 TAF6L ZMIZ2 TNS1 PLPPR2 PLXNA1 RBM38 | 1.11e-07 | 198 | 154 | 11 | 3286_UP |
| Drug | N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine | 2.47e-07 | 9 | 154 | 4 | ctd:C518313 | |
| Drug | pyro-Glu-His-Gly | 5.98e-06 | 6 | 154 | 3 | CID003918406 | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; HL60; HT_HG-U133A | 6.89e-06 | 193 | 154 | 9 | 2567_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 7.19e-06 | 194 | 154 | 9 | 3245_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 7.19e-06 | 194 | 154 | 9 | 4361_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HG-U133A | ATXN2L SETD1A EXTL3 ESRP2 RBMS3 DNAJC1 ADAMTSL4 SEC23A RBFOX2 | 7.49e-06 | 195 | 154 | 9 | 489_DN |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 7185_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 7486_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 6621_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | RABEP2 ATXN2L A1CF POLR2A KIAA0319L TRIOBP EXTL3 ZMIZ2 SYNGR1 | 8.14e-06 | 197 | 154 | 9 | 3372_DN |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 8.47e-06 | 198 | 154 | 9 | 3258_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; HL60; HT_HG-U133A | 8.82e-06 | 199 | 154 | 9 | 3121_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.82e-06 | 199 | 154 | 9 | 3543_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; HL60; HT_HG-U133A | 9.19e-06 | 200 | 154 | 9 | 2395_UP | |
| Drug | SL 327 | 2.28e-05 | 25 | 154 | 4 | ctd:C424127 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 4.87e-05 | 191 | 154 | 8 | 1665_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.05e-05 | 192 | 154 | 8 | 2450_UP | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 5.24e-05 | 193 | 154 | 8 | 3139_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 5.24e-05 | 193 | 154 | 8 | 5268_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A | 5.43e-05 | 194 | 154 | 8 | 5609_UP | |
| Drug | Pivampicillin [33817-20-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.43e-05 | 194 | 154 | 8 | 3506_DN | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 1821_UP | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 3482_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 5052_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 5276_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 2092_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 4547_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 5045_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 3351_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 3786_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 2766_UP | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 3051_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 6019_DN | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 5104_UP | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 2506_UP | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 2964_DN | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 6165_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 6080_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 3023_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 2848_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 1702_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; HL60; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 2539_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 4313_DN | |
| Drug | tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A | 6.73e-05 | 200 | 154 | 8 | 375_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 3062_DN | |
| Drug | AC1NRABQ | 8.95e-05 | 35 | 154 | 4 | CID005287800 | |
| Drug | imidacloprid | 8.95e-05 | 35 | 154 | 4 | ctd:C082359 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.68e-04 | 171 | 154 | 7 | 3318_UP | |
| Drug | Reductoleptomycin a | 1.68e-04 | 41 | 154 | 4 | CID006448769 | |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.87e-04 | 174 | 154 | 7 | 1276_DN | |
| Drug | fullerene C60 | ATXN2L MRPL21 RBPMS BEAN1 POLR2A GTSE1 ASH1L SREBF1 AKNA RSPH6A MEIS3 BCAR1 TAF6L JUNB MFAP4 NAA35 LDB3 ZMIZ2 AHR ARHGAP27 TMC5 TNS1 ADAMTSL4 | 1.88e-04 | 1498 | 154 | 23 | ctd:C069837 |
| Drug | N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide | 1.92e-04 | 17 | 154 | 3 | ctd:C090413 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 2.07e-04 | 177 | 154 | 7 | 2678_UP | |
| Drug | 8-Hydroxy-2-(di-n-propylamino)tetralin | 2.72e-04 | 19 | 154 | 3 | ctd:D017371 | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.90e-04 | 187 | 154 | 7 | 6948_DN | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 2.99e-04 | 188 | 154 | 7 | 3701_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 6022_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 6839_DN | |
| Drug | Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 5344_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 3.29e-04 | 191 | 154 | 7 | 3815_DN | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A | 3.40e-04 | 192 | 154 | 7 | 3807_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 3.40e-04 | 192 | 154 | 7 | 2722_DN | |
| Drug | Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.40e-04 | 192 | 154 | 7 | 2785_DN | |
| Drug | STOCK1N-35215; Down 200; 10uM; MCF7; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 6422_DN | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 4676_UP | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 4118_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.51e-04 | 193 | 154 | 7 | 3773_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 3422_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 6835_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 3308_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 4642_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 2959_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.62e-04 | 194 | 154 | 7 | 4325_DN | |
| Drug | NSC369326 | 3.69e-04 | 21 | 154 | 3 | CID000055646 | |
| Drug | SC-560; Down 200; 10uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 6870_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 1269_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.73e-04 | 195 | 154 | 7 | 1012_UP | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 5673_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 3300_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; HL60; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 2460_DN | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 2901_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.73e-04 | 195 | 154 | 7 | 7327_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 2236_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 2318_DN | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 2784_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; HL60; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 3066_DN | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; PC3; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 5742_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 5091_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; HL60; HG-U133A | 3.85e-04 | 196 | 154 | 7 | 1379_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A | 3.85e-04 | 196 | 154 | 7 | 1713_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 6923_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 1158_UP | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 6744_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 3844_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 3567_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 3738_UP | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 4491_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 3847_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 3.85e-04 | 196 | 154 | 7 | 2314_DN | |
| Disease | cortical surface area measurement | RABEP2 IL34 ATXN2L TCF7L2 STON1 ROR1 SREBF1 TRIOBP MECOM PLXND1 EXTL3 TENM2 DACT1 AFAP1 DMRT2 TNRC6A PLCL1 QSER1 PAX7 ARHGAP27 TNS1 TCF7L1 | 1.63e-06 | 1345 | 152 | 22 | EFO_0010736 |
| Disease | neuroimaging measurement | SECISBP2L IL34 ATXN2L TCF7L2 ROR1 CNKSR2 PLXND1 STAM CRMP1 DACT1 AFAP1 TNRC6A PLCL1 QSER1 PAX7 ARHGAP27 TMC5 PRDM16 TNS1 | 2.73e-06 | 1069 | 152 | 19 | EFO_0004346 |
| Disease | mean platelet volume | WIPF1 PCDHGB6 PCDHGB3 POLR2A DAZAP2 MECOM SORBS1 RSPH6A PLXND1 BCOR ZFPM2 AFAP1 ZMIZ2 TNRC6A SMAP2 PRDM16 ULK2 RBM38 | 5.63e-06 | 1020 | 152 | 18 | EFO_0004584 |
| Disease | Parkinson disease | RABEP2 SETD1A ASH1L SREBF1 HEATR6 RBMS3 IGSF9B PAX7 ARHGAP27 TMC5 | 6.93e-06 | 321 | 152 | 10 | MONDO_0005180 |
| Disease | cognitive function measurement | IL34 ATXN2L DMXL2 TCF7L2 A1CF MAN2A1 POLR2A TRIOBP KMT2E CSMD3 ZFPM2 LSR KMT2D FAM120A ATXN1 ZMIZ2 LRRC53 TNRC6A IGSF9B PLCL1 DNAH5 | 1.55e-05 | 1434 | 152 | 21 | EFO_0008354 |
| Disease | myotonic dystrophy type 1 (is_marker_for) | 2.64e-05 | 2 | 152 | 2 | DOID:11722 (is_marker_for) | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 2.64e-05 | 2 | 152 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.85e-05 | 12 | 152 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease | SETD1A TCF7L2 STON1 MECOM VARS2 AFAP1 DMRT2 RBMS3 QSER1 DNAH5 TNS1 HSPA4 TCF7L1 | 6.08e-05 | 688 | 152 | 13 | EFO_0000341 |
| Disease | cortical thickness | IL34 TCF7L2 STON1 ROR1 SREBF1 TRIOBP MECOM PLXND1 TENM2 CRMP1 DACT1 SHF TNRC6A QSER1 PAX7 TNS1 ULK2 | 6.41e-05 | 1113 | 152 | 17 | EFO_0004840 |
| Disease | intraocular pressure measurement | IL34 MXRA5 TCF7L2 TRIOBP MECOM FOXA1 LDB3 AFAP1 GMDS PRDM16 TNS1 | 7.04e-05 | 509 | 152 | 11 | EFO_0004695 |
| Disease | vital capacity | ATXN2L BEST1 STON1 FRMPD1 MECOM EYA2 KMT2E TENM2 HOXA3 DMRT2 ZNF341 AHR LRP6 GMDS PLCL1 TNS1 PLXNA1 GAB1 | 7.10e-05 | 1236 | 152 | 18 | EFO_0004312 |
| Disease | health study participation | 7.13e-05 | 195 | 152 | 7 | EFO_0010130 | |
| Disease | alcohol consumption measurement | SECISBP2L ATXN2L SETD1A TCF7L2 GALNT7 CSMD3 TENM2 DACT1 DLGAP3 ATXN1 RBM27 RBMS3 TNRC6A NR5A1 IGSF9B ARHGAP27 DNAH5 PRDM16 | 7.55e-05 | 1242 | 152 | 18 | EFO_0007878 |
| Disease | grey matter volume measurement | 7.83e-05 | 44 | 152 | 4 | EFO_0005420 | |
| Disease | brain measurement, neuroimaging measurement | IL34 ATXN2L TCF7L2 ROR1 TRIOBP CRMP1 DACT1 AFAP1 TNRC6A PRDM16 TNS1 | 1.39e-04 | 550 | 152 | 11 | EFO_0004346, EFO_0004464 |
| Disease | Colorectal Carcinoma | TCF7L2 CNKSR2 STAM LGR5 CSMD3 DACT1 KMT2C NPAP1 KDF1 PLPPR2 ZMYM4 SMAD2 | 2.94e-04 | 702 | 152 | 12 | C0009402 |
| Disease | open-angle glaucoma | 4.82e-04 | 191 | 152 | 6 | EFO_0004190 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 4.91e-04 | 30 | 152 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | verbal-numerical reasoning measurement | 6.00e-04 | 131 | 152 | 5 | EFO_0008394 | |
| Disease | Gonadal Dysgenesis, 46,XY | 7.23e-04 | 8 | 152 | 2 | C0018054 | |
| Disease | alcohol drinking | 8.28e-04 | 81 | 152 | 4 | EFO_0004329 | |
| Disease | low tension glaucoma | 9.27e-04 | 9 | 152 | 2 | EFO_1001022 | |
| Disease | post-operative sensory disturbance | 9.27e-04 | 9 | 152 | 2 | EFO_0005324 | |
| Disease | household income | 1.04e-03 | 304 | 152 | 7 | EFO_0009695 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.11e-03 | 398 | 152 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | coronary artery disease | TCF7L2 STON1 SREBF1 MECOM CNKSR2 RSPH6A BCAR1 ZFPM2 ENAM GMDS PLCL1 KDF1 PRDM16 TNS1 SMAD2 | 1.33e-03 | 1194 | 152 | 15 | EFO_0001645 |
| Disease | Malignant neoplasm of breast | PCDHGB6 ROR1 FRMPD1 MECOM SORBS1 BCAR1 FOXA1 HOXA3 KMT2D GLI1 AHR TNS1 TCF7L1 GAB1 | 1.36e-03 | 1074 | 152 | 14 | C0006142 |
| Disease | Neurodevelopmental Disorders | 1.38e-03 | 93 | 152 | 4 | C1535926 | |
| Disease | Microphthalmos | 1.41e-03 | 11 | 152 | 2 | C0026010 | |
| Disease | Ductal Carcinoma | 1.41e-03 | 11 | 152 | 2 | C1176475 | |
| Disease | 46,XY partial gonadal dysgenesis | 1.41e-03 | 11 | 152 | 2 | C4510744 | |
| Disease | subiculum volume | 1.42e-03 | 43 | 152 | 3 | EFO_0009399 | |
| Disease | Familial dilated cardiomyopathy | 1.52e-03 | 44 | 152 | 3 | C0340427 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.62e-03 | 45 | 152 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | serine protease 27 measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0008280 | |
| Disease | open-angle glaucoma (is_implicated_in) | 1.68e-03 | 12 | 152 | 2 | DOID:1067 (is_implicated_in) | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | cup-to-disc ratio measurement | 1.80e-03 | 430 | 152 | 8 | EFO_0006939 | |
| Disease | Male sterility | 1.96e-03 | 48 | 152 | 3 | C0917731 | |
| Disease | Male infertility | 1.96e-03 | 48 | 152 | 3 | C0021364 | |
| Disease | Subfertility, Male | 1.96e-03 | 48 | 152 | 3 | C0848676 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.98e-03 | 13 | 152 | 2 | C1846647 | |
| Disease | colon carcinoma (is_marker_for) | 1.98e-03 | 13 | 152 | 2 | DOID:1520 (is_marker_for) | |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 1.98e-03 | 13 | 152 | 2 | EFO_0020131 | |
| Disease | sodium measurement | 2.02e-03 | 103 | 152 | 4 | EFO_0009282 | |
| Disease | response to bronchodilator, FEV/FEC ratio | TCF7L2 ZPLD1 ROR1 CNKSR2 EYA2 TENM2 LDB3 AFAP1 RBMS3 DNAH5 PRDM16 | 2.13e-03 | 766 | 152 | 11 | EFO_0004713, GO_0097366 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 2.30e-03 | 14 | 152 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | caudate volume change measurement | 2.30e-03 | 14 | 152 | 2 | EFO_0021491 | |
| Disease | Left ventricular noncompaction | 2.30e-03 | 14 | 152 | 2 | C1960469 | |
| Disease | myocardial infarction | 2.32e-03 | 350 | 152 | 7 | EFO_0000612 | |
| Disease | total blood protein measurement | 2.36e-03 | 449 | 152 | 8 | EFO_0004536 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.51e-03 | 355 | 152 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Antihypertensive use measurement | 2.58e-03 | 265 | 152 | 6 | EFO_0009927 | |
| Disease | forced expiratory volume | ATXN2L SETD1A BEST1 STON1 MECOM HOXA3 DMRT2 PLCL1 TNS1 HSPA4 GAB1 | 2.67e-03 | 789 | 152 | 11 | EFO_0004314 |
| Disease | Metastatic melanoma | 2.74e-03 | 54 | 152 | 3 | C0278883 | |
| Disease | breast cancer (is_marker_for) | 2.76e-03 | 185 | 152 | 5 | DOID:1612 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | RBPMS A1CF MAP1A ASH1L TRIOBP CSMD3 TENM2 ZNF768 RBMS3 ZMIZ2 KDF1 HSPA4 | 2.82e-03 | 914 | 152 | 12 | EFO_0004532 |
| Disease | myeloid white cell count | PRUNE2 TCF7L2 RBPMS SREBF1 MECOM KMT2E ZFPM2 GGT5 HOXA3 ATXN1 TCF7L1 RBM38 | 3.45e-03 | 937 | 152 | 12 | EFO_0007988 |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.82e-03 | 18 | 152 | 2 | EFO_1000649, HP_0000131 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 3.82e-03 | 18 | 152 | 2 | OBA_2045110 | |
| Disease | Myeloid Leukemia | 3.82e-03 | 18 | 152 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.82e-03 | 18 | 152 | 2 | C0023466 | |
| Disease | bone density | 4.09e-03 | 388 | 152 | 7 | EFO_0003923 | |
| Disease | white matter microstructure measurement | 4.21e-03 | 390 | 152 | 7 | EFO_0005674 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.26e-03 | 19 | 152 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 4.26e-03 | 19 | 152 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 4.26e-03 | 19 | 152 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 4.44e-03 | 64 | 152 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | mean arterial pressure | 4.46e-03 | 499 | 152 | 8 | EFO_0006340 | |
| Disease | FEV/FEC ratio | MECOM CNKSR2 RSPH6A AFAP1 RBMS3 NETO1 GMDS PLCL1 DNAH5 PRDM16 TNS1 PLPPR2 HSPA4 TCF7L1 | 4.57e-03 | 1228 | 152 | 14 | EFO_0004713 |
| Disease | apolipoprotein A 1 measurement | IL34 STON1 MAP1A AKNA PUM2 RSPH6A ZFPM2 LDB3 GLI1 ZMIZ2 TCF7L1 | 4.59e-03 | 848 | 152 | 11 | EFO_0004614 |
| Disease | serum homoarginine measurement | 4.71e-03 | 20 | 152 | 2 | EFO_0005421 | |
| Disease | citrulline measurement | 4.71e-03 | 20 | 152 | 2 | EFO_0009777 | |
| Disease | white matter hyperintensity measurement | 4.88e-03 | 302 | 152 | 6 | EFO_0005665 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APYPSTYPVRPELQG | 111 | O95429 | |
| ELDYPMGSFEPSPYP | 716 | P35869 | |
| DYRAEYVPSTPSPVP | 831 | Q4VCS5 | |
| YSPSPLTAAPIGLGY | 1386 | Q9NR48 | |
| PGVFYQYVISSPPPI | 591 | Q6UY14 | |
| GPSGVILSPNYPEPY | 1451 | Q7Z408 | |
| TGVILSPGYPDSYPN | 2466 | Q7Z407 | |
| PYPYSLSEPAPLTLD | 41 | Q5T035 | |
| DPTTTYLGAPVFYAP | 336 | Q9NQ94 | |
| TYQPQPDSVYLVPTP | 106 | P56945 | |
| PPPLPTSSLPEGYYE | 81 | Q8N556 | |
| DYTVSPYAITPPPAA | 166 | Q7LC44 | |
| VLYGPDDPTISPSYT | 411 | P06731 | |
| YGPDTPIISPPDSSY | 591 | P06731 | |
| YPRPYPSEELSGPSP | 306 | C9J069 | |
| RPGYYSAPQTPLSPT | 461 | O76090 | |
| GPPPNYINTYPTDLS | 2566 | Q8TDJ6 | |
| YATPQPGTPVSPVQY | 106 | P54253 | |
| SYLPYPAPEGIAVSP | 656 | Q6W2J9 | |
| PKPEFPVYTPLETTY | 281 | Q96KC8 | |
| PALSASTPSPYPYIG | 1011 | Q8WWM7 | |
| EPYELTVPALYPSSP | 131 | Q93062 | |
| PTPLVPDTYEPDGYN | 476 | Q9P2N5 | |
| PVPSLSSPYIEYTPA | 161 | Q9H0Z9 | |
| GIFTSPNYPSKYPPD | 51 | Q8TDF5 | |
| GTYIPQYTPVPPTAV | 376 | Q6XE24 | |
| GTDIYLPYTPPSSES | 1106 | Q2KHR3 | |
| TLVPEGIYLPPPGYQ | 271 | Q9H5N1 | |
| GIYLPPPGYQLVPDT | 276 | Q9H5N1 | |
| SLPLVPGFPYPTAAT | 261 | O43251 | |
| SPEPPSLYGALNPQY | 91 | P78412 | |
| LYPAPAYTPELGLVP | 821 | Q9H3S7 | |
| PYIISAAPPGTDPYT | 311 | Q8TB72 | |
| GPVVPPNYSEGTLPY | 736 | Q9Y5F9 | |
| GMPTLPPYQLPDSTY | 296 | P23759 | |
| PPYQLPDSTYPTTTI | 301 | P23759 | |
| GSPYKAPIYIPDDIP | 61 | Q03112 | |
| QAPPYTDAPPAYSEL | 31 | Q15038 | |
| PAYTYGSPSPPDPRD | 61 | Q06828 | |
| LPTEPPYTAYVGNLP | 36 | Q15056 | |
| YDLPPPPYSSDTESL | 271 | Q86YD5 | |
| YSQPPGTPRPVVDSY | 2131 | Q8NEZ4 | |
| PTFSYAALAGPTVPP | 2031 | P78559 | |
| YSSPQDLPYPDPAIA | 446 | P34932 | |
| YTPSPAPNYNPAPSV | 461 | O75112 | |
| LPDGNAKPYVYTTPP | 811 | Q16706 | |
| PQKETTPFYPRSPYG | 166 | O60547 | |
| PQGTYGLPPASYPAS | 301 | O43365 | |
| GPESYVPPYRPSLEE | 396 | Q15742 | |
| AVPQPVAPSYSYATP | 276 | Q8IZA0 | |
| SYDIPPTPGNTYQIP | 306 | Q13480 | |
| APKPVLYPPSAEYAT | 1226 | A6NM62 | |
| GSPYSLPYAVPPNFL | 141 | P0C7T5 | |
| GSSSYPPVIYSPLMP | 531 | Q8WW38 | |
| VKGYPPNSPYIGSSP | 731 | Q5JUK3 | |
| TALQYPPPAYPAAKG | 231 | P18146 | |
| YYPDPVLEPLSPTGL | 1146 | Q9UIW2 | |
| YYPDPSFEPLGPSGV | 1121 | P51805 | |
| PSDPPPGAQSYAYLA | 286 | Q9Y4D7 | |
| LPGPSTYALPSIYPS | 146 | O00443 | |
| GQSPYFSYPLTPATP | 191 | O00443 | |
| MPTVLYPTPLPQYDG | 281 | Q6AI08 | |
| GYKPIYSPVTPVTPG | 926 | Q8IZD2 | |
| YTSDLNYDSEPVPPP | 1556 | O75581 | |
| LASFPETVPAVPGPY | 21 | Q99687 | |
| FDPYLPTSVYSPQPP | 676 | P08151 | |
| QSGPYTQPPPDYLPS | 861 | P08151 | |
| GPYPYSLSEPAPLTL | 391 | Q9NZB2 | |
| ALYSSPGPKYLIPPT | 21 | Q96PU9 | |
| VPGVLPTYSERTLPY | 736 | Q9Y5G1 | |
| TYYLSDSPLLGPPVG | 146 | Q9NYZ3 | |
| YESLPAPGPPFVSYV | 56 | Q8N485 | |
| YAKPYPGPEAASRVP | 56 | Q96GM1 | |
| PPVVDPYDMPGTSYS | 91 | P53539 | |
| YSPYGSTLPASLPLG | 426 | P55317 | |
| PEPSLQYAATQLYPP | 201 | Q6ZMJ4 | |
| NVGLYPAPVPLPYAS | 701 | Q9NYF0 | |
| PPPILNGRISYYSTP | 26 | P20023 | |
| NSYKSAYSPSPVEPP | 281 | Q9Y5R5 | |
| YYDAADKLTPPGPPS | 771 | Q5SYB0 | |
| PPPIYVGSSPTLKNY | 451 | Q86SF2 | |
| GPVETEPPYASPRYL | 576 | O43909 | |
| DTTYPYFSPPQELPG | 111 | Q4G0X9 | |
| EGYPLPYEPPATDGS | 741 | O95886 | |
| LEVPLGDYTLYSPPP | 271 | P36269 | |
| AYISSVPIMPYPPAA | 1341 | Q7Z591 | |
| APTTEPTKPPYSYIA | 11 | O43638 | |
| VPVVYVDYPGPASLT | 2731 | Q14204 | |
| SSYQPAVYPEEIPSP | 541 | Q9NRM1 | |
| YAEPLPITGPEYATP | 666 | Q96PD2 | |
| ATQLYVPTDAPPPYS | 156 | Q3B7T3 | |
| NSLPEYPTVPSYPGS | 211 | Q969E2 | |
| GPVYEVPATPKYATP | 501 | Q14194 | |
| YPSDTTPEYGSILVP | 2551 | Q8TE73 | |
| ITYDLPPSSVPSPAY | 876 | O75473 | |
| YPPAPPPYSETDSQA | 616 | Q86X29 | |
| AGIQQATPYTAYPPP | 76 | O00167 | |
| GYLDTPVVSYPPFPG | 461 | Q9H0K4 | |
| VSGPLPPAYSPRYVE | 96 | Q5ST30 | |
| AFPAPYGPSPASRYV | 581 | Q9Y6J9 | |
| APPPPGIDVTTYYST | 381 | Q12872 | |
| RAIKSEYPEPYASPP | 191 | Q13285 | |
| YPGSYSPQDPSAGPL | 161 | Q9NQG5 | |
| VSSPPPYTAYAAPAP | 126 | Q96CS7 | |
| PYTPPFDLSYLTEPA | 2391 | Q8WUY3 | |
| TYILPPSGDPCYSPL | 2056 | A2VEC9 | |
| PVPVTIRGAVPAPYY | 626 | A6NFQ2 | |
| PYTPQPPDLYDTNTS | 1641 | P21675 | |
| TPKEGSPYEAPVYIP | 61 | Q9HAZ2 | |
| SDGVYLIYPSGPSVP | 51 | P55083 | |
| SSERSTPPYLFPEYP | 616 | Q8TE76 | |
| PPTPETDYPESLTSY | 356 | Q6ZUM4 | |
| PTGPYFAYPIISAQP | 86 | Q93073 | |
| GYPLTSGTVYTPPPR | 336 | Q9NT68 | |
| YPSPPVSPTTVGYLT | 641 | Q9H6T0 | |
| VYPYPRATSPAPDAD | 171 | Q8NAX2 | |
| ASQTLVPPAYAPYPS | 111 | Q01892 | |
| YTSAAAYIPGLDPPT | 1081 | Q9NZP6 | |
| TAERFPPSYTSYLPP | 401 | O15047 | |
| YPAAYGAPLTSPEPS | 996 | Q9H2D6 | |
| PILYAYSFSGPPEPV | 621 | Q15436 | |
| APSPPTTYGYISVPT | 821 | Q8WZ75 | |
| APAPPQFSSTPVLGY | 151 | P36956 | |
| STPKQDSPPPPYDTY | 696 | Q8WXI2 | |
| ISASYPPYQATGPPN | 146 | Q99816 | |
| GPPPTASPGYSDEYE | 151 | Q01973 | |
| YTEAPLPSESYLPSP | 516 | Q15111 | |
| TATQPLPLYDTPYEP | 156 | Q7M4L6 | |
| PVYPTPTVYSPGKQG | 256 | Q9BYN7 | |
| SGYIDTPDPPTIISY | 131 | Q8TCW7 | |
| YSPPPQSPELYVAAS | 646 | Q5VZE5 | |
| PLSSPIVDFYFSPGP | 61 | Q9Y6Q2 | |
| MAYPTAYPSFPGVTP | 291 | Q8WU79 | |
| SPYYPLSPGAVGQIP | 231 | Q9HCS4 | |
| SSSSPGEVEPPPFYV | 971 | Q9UPX0 | |
| YIPETPPPGYISEDG | 216 | Q15796 | |
| TSPAYEPRSPGGYTP | 1596 | P24928 | |
| PTPEISSETPGYIYS | 641 | Q9BX66 | |
| PSFPVSPAYYPGLSS | 1351 | Q9HBL0 | |
| PGYPFIMIPDLTSPY | 101 | Q9NQB0 | |
| PPDISPYYPLSPGTV | 236 | Q9NQB0 | |
| SQSPRYEPQSPGYEP | 116 | Q9H5H4 | |
| YPEVFEPPLTGYPGE | 336 | P49810 | |
| DSSMPYAPYVEPTGP | 191 | O43759 | |
| NTYPSQAPVYSPPPA | 471 | Q92783 | |
| DLPPPEPYVQTTKSY | 461 | O43516 | |
| YLPGYVPKTSLSSPP | 46 | Q7Z2W9 | |
| PASYPSPPGYIFDNT | 366 | Q658L1 | |
| LAEFTPGPPPISYQS | 771 | Q8NF64 | |
| GGSEYKYTPPTQPPI | 256 | Q9UET6 | |
| PPGAEAAPSLRYVPY | 781 | Q8IYT8 | |
| AAPSLRYVPYGASPP | 786 | Q8IYT8 | |
| TRPDYPGSLAEPNYP | 61 | Q6UXY8 | |
| QNPSPGAYILPSYPV | 806 | Q9Y4F4 | |
| APSPGYPQQSPYPAT | 291 | A5D8V6 | |
| PAFLPSAPGPTMSYY | 406 | Q9UL17 | |
| YPNIDPETDPYVTPG | 1621 | Q8NDV7 | |
| LYTQYAPVPFGIPVP | 996 | Q5VZL5 | |
| STAGDPPIPYLTTYG | 76 | Q9BYJ9 | |
| GVYAGPEPPPVYTNL | 171 | P17275 | |
| PGSYTDPYAQPPLTP | 2371 | O14686 | |
| EYFGDPLTPYLPAVP | 251 | Q9UQQ1 | |
| YPPRITSEPTPVIYT | 2731 | Q9NR99 |